Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
-
最新报道：Hims & Hers Health Inc. announced plans to offer a generic version of Novo Nordisk's popular weight-loss drug semaglutide in Canada, aiming to provide a more affordable alternative to branded medications like Ozempic and Wegovy. The telehealth company will source the generic from a licensed Canadian manufacturer, though pricing details remain undisclosed. This move comes as demand for GLP-1 receptor agonists surges globally, with Novo Nordisk struggling to meet supply needs. Hims & Hers CEO Andrew Dudum stated the initiative aligns with their mission to expand access to essential medications, particularly in weight management where costs often create barriers to treatment.
下一篇
Bitget Launchpool project RCADE is now open for investment
- According to the news from Bijie.com, Bitget's current Launchpool project RCADE Network (R...
24小时热点
热点专题
413635